Secondary prevention strategies in ischemic strike: Identification and optimal management of modifiable risk factors

被引:23
作者
Flemming, KD [1 ]
Brown, RD [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA
关键词
D O I
10.4065/79.10.1330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The identification and treatment of modifiable ischemic stroke risk factors, in addition to appropriate antithrombotic therapy, can reduce the likelihood of first or recurrent stroke, prevent long-term morbidity and mortality after first stroke or transient ischemic attack, and lower health care costs. Long-term morbidity and mortality in patients with ischemic stroke includes patients with coronary artery disease. Therefore, in patients with ischemic stroke (especially those with carotid artery disease and lacunar disease), the goal is to prevent not only recurrent stroke but also coronary artery disease. Neurologists and general practitioners must be aware of the specific risk factors and recommendations for patients with ischemic stroke and apply the information systematically. We review known risk factors for ischemic stroke and current recommendations for treatment, focusing primarily on atherosclerotic risk factors as they apply to patients with stroke. In particular, recent data on hypertension and hyperlipidemia are described. In addition, we discuss the challenges in managing these risk factors and the potential strategies for overcoming them.
引用
收藏
页码:1330 / 1340
页数:11
相关论文
共 118 条
[61]   One year after CAPRIE, IST and ESPS 2 - Any changes in concepts? [J].
Hankey, GJ .
CEREBROVASCULAR DISEASES, 1998, 8 :1-7
[62]   EFFECTS OF INTENSIVE MULTIPLE RISK FACTOR REDUCTION ON CORONARY ATHEROSCLEROSIS AND CLINICAL CARDIAC EVENTS IN MEN AND WOMEN WITH CORONARY-ARTERY DISEASE - THE STANFORD-CORONARY-RISK-INTERVENTION-PROJECT (SCRIP) [J].
HASKELL, WL ;
ALDERMAN, EL ;
FAIR, JM ;
MARON, DJ ;
MACKEY, SF ;
SUPERKO, HR ;
WILLIAMS, PT ;
JOHNSTONE, IM ;
CHAMPAGNE, MA ;
KRAUSS, RM ;
FARQUHAR, JW .
CIRCULATION, 1994, 89 (03) :975-990
[63]   Effects of estrogen plus progestin on health-related quality of life [J].
Hays, J ;
Ockene, JK ;
Brunner, RL ;
Kotchen, JM ;
Manson, JE ;
Patterson, RE ;
Aragaki, AK ;
Shumaker, SA ;
Brzyski, RG ;
LaCroix, AZ ;
Granek, IA ;
Valanis, BG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) :1839-1854
[64]   HMG-CoA reductase inhibitors (statins) - A promising approach to stroke prevention [J].
Hess, DC ;
Demchuk, AM ;
Brass, LM ;
Yatsu, FM .
NEUROLOGY, 2000, 54 (04) :790-796
[65]   EFFICACY OF CAROTID ENDARTERECTOMY FOR ASYMPTOMATIC CAROTID STENOSIS [J].
HOBSON, RW ;
WEISS, DG ;
FIELDS, WS ;
GOLDSTONE, J ;
MOORE, WS ;
TOWNE, JB ;
WRIGHT, CB .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) :221-227
[66]  
Hodis HN, 1995, J CARDIOVASC PHARM, V25, pS25
[67]   Stroke prevention - Narrowing the evidence-practice gap [J].
Holloway, RG ;
Benesch, C ;
Rush, SR .
NEUROLOGY, 2000, 54 (10) :1899-1906
[68]   SERUM-CHOLESTEROL LEVELS AND 6-YEAR MORTALITY FROM STROKE IN 350,977 MEN SCREENED FOR THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
ISO, H ;
JACOBS, DR ;
WENTWORTH, D ;
NEATON, JD ;
COHEN, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (14) :904-910
[69]   Risk factor modification,in stroke prevention - The experience of a stroke clinic [J].
Joseph, LN ;
Babikian, VL ;
Allen, NC ;
Winter, MR .
STROKE, 1999, 30 (01) :16-20
[70]   Stroke risk management - Changes in mainstream practice [J].
Kalra, L ;
Perez, I ;
Melbourn, A .
STROKE, 1998, 29 (01) :53-57